Alterity Therapeutics Limited (ATHE) Financials
ATHE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 31.8 million | 2.3 million |
| March 31, 2026 | ? | ? |
| Dec. 31, 2025 | 38.0 million | 1.8 million |
| June 30, 2025 | 30.3 million | 2.4 million |
ATHE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| March 31, 2026 | -3.2 million | ? |
| Dec. 31, 2025 | -3.5 million | ? |
| June 30, 2025 | -1.5 million | -92947 |
ATHE Net Income
No data available :(
ATHE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 25.8 million | - | 95590 |
| March 31, 2026 | - | - | - |
| Dec. 31, 2025 | 32.8 million | - | 43679 |
| June 30, 2025 | 26.7 million | - | 102230 |
ATHE Shares Outstanding
ATHE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 8.8 million | 6.9 million | 3.9 million | - |
| March 31, 2026 | - | - | - | - |
| Dec. 31, 2025 | 7.0 million | 5.1 million | 3.4 million | - |
| June 30, 2025 | - | 5.7 million | 1.4 million | -221088 |
ATHE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 40405 |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | 37957 |
| June 30, 2025 | 2.5 million | 42037 |
ATHE
Price: $3.12
52 week price:
Earnings Per Share: -0.96 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 8900
Market Capitalization: 58.4 million